Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to rise 16.44% to -10 cents per share on August 17

Q2'26

Est.

$-0.10

Q1'26

Beat

by $0.03

Q4'25

Est.

$-0.13

Q3'25

Beat

by $0.05

Q2'25

Missed

by $0.08

The last earnings report on May 13 showed earnings per share of -9 cents, beating the estimate of -11 cents. With 3.32M shares outstanding, the current market capitalization sits at 310.83M.

View a ticker or compare two or three

Compare

HUMA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HUMA